Hypertension Diagnostics taps into Korean market:
This article was originally published in Clinica
Seoul, South Korea-based JY Trading Co has been granted exclusive distribution rights to the product range of cardiovascular profiling systems company Hypertension Diagnostics (HDI). The deal opens significant market opportunities for St Paul, Minnesota-based HDI. Cardiovascular disease is the leading cause of death in Korea, and 25% of the adult population suffer from hypertension, says HDI president Greg Guettler.
You may also be interested in...
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.